SABS - BBIG NAOV and ISPO among pre market losers
SELLAS Life Sciences SLS -39% plunged 24% on $25M stock offering. ARCA biopharma ABIO -22% fails to meet key goal in mid-stage trial for COVID-19 therapy. Redwire RDW -18% on Q4 results. Blend Labs BLND -18% on Q4 results. Nuvve Holding NVVE -15% on Q4 results. 4D pharma LBPS -11% on FY results. Milestone Scientific MLSS -8% on FY results. NanoVibronix (NAOV) -7%. Innovative Industrial Properties IIPR -7% launches offering of 1M common shares. Inspirato (ISPO) -6%. SAB Biotherapeutics (SABS) -5%. Vinco Ventures (BBIG) -5%.
For further details see:
BBIG, NAOV and ISPO among pre market losers